Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations

v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Revenues:        
Total revenues $ 3,063,029 $ 2,359,830 $ 8,981,421 $ 7,243,512
Costs and expenses:        
Costs of revenues 1,175,689 993,885 3,544,581 2,917,522
Research and development 338,043 321,590 1,007,345 953,222
Selling, general and administrative 248,905 237,514 767,028 714,403
Impairment of goodwill and purchased intangible assets 0 70,474 239,100 289,474
Interest expense 71,889 79,981 229,041 228,417
Other expense (income), net (35,930) (45,622) (121,323) (104,515)
Income before income taxes 1,264,433 702,008 3,315,649 2,244,989
Provision for income taxes 176,017 100,467 456,855 319,539
Net income $ 1,088,416 $ 601,541 $ 2,858,794 $ 1,925,450
Net income per share        
Basic (in dollars per share) $ 8.21 $ 4.46 $ 21.44 $ 14.20
Diluted (in dollars per share) $ 8.16 $ 4.43 $ 21.32 $ 14.11
Weighted-average number of shares:        
Basic (in shares) 132,607 134,954 133,361 135,638
Diluted (in shares) 133,303 135,856 134,066 136,428
Product        
Revenues:        
Total revenues $ 2,393,821 $ 1,769,369 $ 7,000,672 $ 5,527,842
Service        
Revenues:        
Total revenues $ 669,208 $ 590,461 $ 1,980,749 $ 1,715,670